Calidi Biotherapeutics News and Activities

Calidi Biotherapeutics is a company listed under the stock ticker CLDI (US).

View the org chart displaying its 11 main executives

Most searched biographies at Calidi Biotherapeutics

• Eric Poma, Chief Executive Officer
• Scott Leftwich, Director
• Allan Camaisa, Director

Popular executive movements at Calidi Biotherapeutics

• Wendy Pizarro, Chief Administrative Officer and Chief Legal Officer, will leave the company on Oct. 17, 2025  (posted on September 30 2025).
• Wendy Pizarro, Chief Administrative Officer and Chief Legal Officer, will leave the company on Oct. 17, 2025  (posted on September 29 2025).

Create your alert
to follow the executive moves at Calidi Biotherapeutics.

Calidi Biotherapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Calidi Biotherapeutics

• Calidi Biotherapeutics - News
• Calidi Biotherapeutics Presents Systemic Oncolytic Platform with CD55-Enhanced Expression and IL-15 Superagonist Payload at ASCO Annual Meeting - Calidi Biotherapeutics, Inc
• News Coverage - Calidi Biotherapeutics, Inc
• Press Release - Calidi Biotherapeutics, Inc
• Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights | Newsroom - Calidi Biotherapeutics
• Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 | Newsroom - Calidi Biotherapeutics
• Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy  Platform at AACR Annual Meeting | Newsroom - Calidi Biotherapeutics
• Calidi Newsroom | Latest Updates & Breakthroughs
• Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor | Newsroom - Calidi Biotherapeutics
• Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement | Newsroom - Calidi Biotherapeutics
• View more press releases Close

Social media about Calidi Biotherapeutics

• Calidi Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Calidi Biotherapeutics on LinkedIn, X (Twitter) & YouTube